NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyOD - NIH Office of the Director
Abstract We will develop a distributed, cloud-based, artificial intelligence (AI) tool for the prediction of chronic kidney disease (CKD) progression and modifiable risk factors for clinical use. Our tool will provide a 5-year risk profile individualized to each patient and will integrate electronic health record (EHR) data, text data, radiology images with corresponding reports, and pathology data, including brightfield histology images and electron microscopy reports. The EHR, text, laboratory, and radiology data from >200K individuals with kidney disease will drive the AI tool development supplemented with histopathologic image data from >1000 individuals. Although histopathologic information has long held prognostic significance for end-stage renal disease, such data is rarely included in clinical kidney failure risk equations due to its complexity. Because the histopathologic manifestations of CKD are broadly distributed across the kidney’s functional units, our tool will facilitate the decomposition of each kidney whole slide image into hundreds of sub-images, comprising >~3M functional units, quantitate pixel-level features, and provide balance among the different modalities for effective learning and generalization. The resulting tool will support: primary care physicians and nephrologists who will benefit from enhanced risk prediction using complex data types, patients who will benefit by identification and prioritization of modifiable risk factors, and nephropathologists who will benefit from the quantitative analytics. An iterative process will incorporate their feedback to enhance the usability and usefulness of our platform. Our platform will be self-adapting, and will ingest and learn from new data as it evolves, improving kidney disease trajectory prediction and therapeutic care.
Up to $2.1M
2026-08-31
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
One-time $749 fee · Includes AI drafting + templates + PDF export
Role of Neutrophils in the Pathogenesis of Cholangiopathies
NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases — up to $3.2M
Vertically transferred antibodies protect babies from Escherichia coli infection
NIAID - National Institute of Allergy and Infectious Diseases — up to $2.8M
Molecular mechanism of metabolic stress in the pancreatic beta cells
NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases — up to $2.8M
Personalized Outreach and Multifaceted Interventions for Screening Enhancement (PROMISE) for Anal and Cervical Cancer Prevention and Treatment
NCI - National Cancer Institute — up to $2.3M
Response of the commensal microbiota to host physiological stress
NIGMS - National Institute of General Medical Sciences — up to $2.1M
CIHR Team Grant
Canadian Institutes of Health Research (CIHR) — up to $2M